Cees-Jan Oostwouder - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Cees-Jan Oostwouder

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Eclinicalmedicine|March 20, 2026

Retraction Notice to "Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study" [eClinicalMedicine 90(2025) 103681]Cees-Jan Oostwouder, Karin Vos, Ivo J Lutke Schipholt, et al.

Eclinicalmedicine|December 24, 2025

Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series studyCees-Jan Oostwouder, Karin Vos, Ivo J Lutke Schipholt, et al.

Pageof 1

Search research articles

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Eclinicalmedicine|March 20, 2026

Retraction Notice to "Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study" [eClinicalMedicine 90(2025) 103681]Cees-Jan Oostwouder, Karin Vos, Ivo J Lutke Schipholt, et al.

Eclinicalmedicine|December 24, 2025

Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series studyCees-Jan Oostwouder, Karin Vos, Ivo J Lutke Schipholt, et al.

Pageof 1